CRWD vs MSFT: Which Is the Better Buy?

Side-by-side comparison of CrowdStrike Holdings, Inc. and Microsoft Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-09.
CrowdStrike Holdings, Inc. Β· Technology
$191.12
+32.7% upside to fair value
Grade B
VS
Microsoft Corporation Β· Technology
$379.40
+45.0% upside to fair value
Grade A High Quality
QuantHub Verdict
MSFT has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRWD MSFT
Current Price $191.12 $379.40
Fair Value Estimate $253.64 $550.13
Upside to Fair Value +32.7% +45.0%
Market Cap $194.6B $2,818.3B
Forward P/E -4023.6x 22.5x
EV / EBITDA 570.3x 14.2x
Price / Sales 38.2x 8.9x
Price / FCF 134.0x 38.6x
Revenue Growth YoY +25.6% +18.3%
Gross Margin 75.0% 68.3%
Operating Margin -3.9% 46.8%
Return on Equity -0.6% 33.1%
Dividend Yield 0% 0%
FCF Yield 0.75% 2.59%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
CRWD β€” CrowdStrike Holdings, Inc.
CrowdStrike Holdings, Inc. operates in the technology sector, specifically in software infrastructure, providing cybersecurity solutions. The business quality is medium due to its strong revenue growth of 25.6% in the most recent quarter and impressive earnings growth of 125.2% in the same period, indicating effective scaling and operational leverage. However, profitability metrics remain challen…
MSFT β€” Microsoft Corporation
Microsoft Corporation is a leading global technology company specializing in cloud computing, productivity software, and enterprise platforms. The company benefits from a very strong and widening competitive moat supported by scale, switching costs, an integrated ecosystem, and disciplined capital allocation including large buybacks and dividends. Its business quality is high, demonstrated by a 3…
Accumulation Zones
Metric CRWD MSFT
Zone Low $190.23 $412.60
Zone High $215.59 $467.61
In Buy Zone? Yes Yes
← CRWD Research    MSFT Research β†’    All Research